Nautilus Biotechnology Inc (NAUT) Straddle

Trading a NAUT straddle lets you take a pure volatility position on Nautilus Biotechnology Inc without committing to a direction. Nautilus Biotechnology Inc's straddle involves buying (or selling) a call and a put at the same strike and expiration, profiting when the stock moves more (or less) than the combined premium implies. Use our scanner to evaluate NAUT straddle pricing in real time and find the moments when expected moves are mispriced.

A long straddle on NAUT profits from large moves in either direction and is a classic play into binary events like earnings, product announcements, or macro releases. A short straddle profits when Nautilus Biotechnology Inc stays range-bound and implied volatility contracts. The breakeven points are simple: strike plus total premium on the upside, strike minus total premium on the downside. Comparing the NAUT straddle price to historical realized moves helps you judge whether the market is overpaying or underpaying for volatility.

Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. It develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. The company was founded in 2016 and is headquartered in Seattle, Washington.

Earnings, product cycles, macro prints — any time volatility itself is the trade, the NAUT straddle is the cleanest expression of that view. Our scanner prices every NAUT straddle against historical realized moves, flags expirations where the market is overpaying or underpaying for vol, and ranks setups by breakeven width and IV rank. Whether you're long a NAUT straddle into a catalyst or short a NAUT straddle to harvest decay, the options straddle setups that matter are all in one place.